Sleep Duration, Sleep Timing, and Sleep Disordered Breathing-Associations With Obesity and Gestational Diabetes in Pregnancy.
Francesca Facco
https://pubmed.ncbi.nlm.nih.gov/33481418Actively Recruiting
Led by The George Washington University Biostatistics Center · Updated on 2026-04-06
1500
Participants Needed
14
Research Sites
N/A
Total Duration
T
The George Washington University Biostatistics Center
Lead Sponsor
E
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborating Sponsor
Researchers are evaluating whether treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) during pregnancy can reduce the rate of hypertensive disorders in pregnant women. This trial focuses on women diagnosed with mild to moderate OSA between 14 weeks 0 days and 21 weeks 6 days of gestation. The study aims to fill the gap in knowledge about whether managing OSA during pregnancy improves maternal and neonatal outcomes. Participants are randomly assigned to one of two groups: one group receives autotitrating CPAP therapy with weekly contact, incentives to encourage use, and initial sleep advice counseling, while the other group receives only initial sleep advice counseling. The CPAP device is used during sleep, and the study includes ongoing support to promote adherence. Treatment continues through pregnancy, with outcomes assessed up to 14 days postpartum. During the study, women will have various assessments including monitoring for hypertensive disorders, gestational diabetes, preterm birth, cesarean delivery, and maternal cardiovascular health. Neonatal outcomes such as birth weight, respiratory support needs, and complications within 72 hours after delivery are also tracked. The study includes safety monitoring through 6 weeks postpartum and collects detailed health data to evaluate the effects of CPAP treatment during pregnancy.
CONDITIONS
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From randomization between 14 weeks 0 days and 21 weeks 6 days gestation until delivery
Participants diagnosed with obstructive sleep apnea receive either continuous positive airway pressure (CPAP) therapy with weekly contact and sleep advice counseling or sleep advice counseling alone during pregnancy.
Weekly visits or contacts during treatment
Duration - Up to 6 weeks postpartum
Participants are monitored for maternal and neonatal outcomes up to 14 days postpartum and maternal health outcomes up to 6 weeks postpartum.
Visits up to 6 weeks postpartum
Total: 14 locations
1
University of Alabama - Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
Regents of the University of California San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
3
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
4
Columbia University
New York, New York, United States, 10032
Actively Recruiting
5
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
6
Case Western Reserve-Metro Health
Cleveland, Ohio, United States, 44109
Actively Recruiting
7
Ohio State University Hospital
Columbus, Ohio, United States, 43210
Actively Recruiting
8
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
9
Magee Women's Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
10
Brown Univeristy
Providence, Rhode Island, United States, 02905
Active, Not Recruiting
11
University of Texas Medical Branch
Galveston, Texas, United States, 77555
Active, Not Recruiting
12
Baylor College of Medicine
Houston, Texas, United States, 77030
Actively Recruiting
13
University of Texas - Houston
Houston, Texas, United States, 77030
Actively Recruiting
14
University of Utah Medical Center
Salt Lake City, Utah, United States, 84132
Actively Recruiting
R
Rebecca Clifton, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Francesca Facco
https://pubmed.ncbi.nlm.nih.gov/33481418